Ceryvyn Therapeutics Ltd (cyv) Logo

Ceryvyn Therapeutics Ltd (CYV)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News
Announcements

CYV ASX Chart

Snapshot

Ceryvyn Therapeutics Limited (CYV, formerly Opthea Limited) is an ASX listed biopharmaceutical company which researches and develops novel therapeutic products based on targeting Vascular Endothelial Growth Factors (VEGF) C, D and R3. Since FY2014, the Company has been committed to the development of new therapies for the treatment of serious eye diseases that affect the back of the eye, or retina, and lead to vision loss. The Company's lead candidate was sozinibercept a VEGF C/D trap inhibitor being developed for use in conjunction with VEGF A inhibitors for the treatment of wet AMD and other retinal diseases.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2026 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -99.58%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,834 of 2,351
Sector Rank 174 of 243

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies -
EPS -$0.185
DPS $0.00
Book Value Per Share -$0.205

Broker Consensus

CYV is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Hawthorn East VIC 3123
Website www.ceryvyn.com
Registry Computershare
Auditor Deloitte Touche Tohmatsu
Date Listed -

Upcoming Calendar (Forecasted)

Date Event
14/09/2026 Report (Annual)
01/03/2027 Report (Interim)

Former Company Names

  • Circadian Technologies Limited (CIR), 11/12/2015, Opthea Limited (OPT), 08/07/2026

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

CYV directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
23/06/26 Jeremy Levin Buy +13,390,000 $0.014 $188,799 On-market trade
19/06/26 Jeremy Levin Issued 48,000,000 $0.014 $672,000 Issue of options
17/06/26 Lawrence Gozlan Sell +1,877,357 $0.015 ($28,160) On-market trade
19/12/25 Katherine(Kathy) Connell Issued 41,000,000 $0.60 $24,600,000 Directors' share plan

Director Interests

The current holdings of CYV directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Jeremy Levin 23/06/2026 13,393,937 N/A 53,000,000 N/A
Lawrence Gozlan 17/06/2026 N/A 0 45,500,000 N/A
Katherine(Kathy) Connell 15/06/2026 N/A 2,000,000 41,500,000 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 5, 2025.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
HSBC Custody Nominees (Australia) Limited 194,136,944 15.77%
Citicorp Nominees Pty Limited 183,915,116 14.94%
Ubs Nominees Pty Ltd 166,500,018 13.52%
Jp Morgan Nominees Australia Pty Limited 138,447,073 11.24%
BNP Paribas Noms Pty Ltd 53,851,264 4.37%
HSBC Custody Nominees(Australia) Limited Gsco Eda 47,047,963 3.82%
HSBC Custody Nominees (Australis) Limited A/C2 44,858,465 3.64%
Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> 40,072,530 3.25%
Merrill Lynch(Australia) Nominees Pty Limited 35,396,820 2.87%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 19,689,961 1.60%
Information Logistics Pty Ltd <Information Logistics A/C> 18,076,530 1.47%
National Nominees Limited 16,523,839 1.34%
HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 10,336,919 0.84%
Jadeglen Investments Pty Ltd <David Thurin Family A/C> 9,004,711 0.73%
Safo Investments Pty Ltd <Safo Investment A/C> 8,134,875 0.66%
M & S Skyleisure Pty Ltd, M & S Skyleisure No 2 A/C> 6,581,336 0.53%
M & S Skyleisure Pty Ltd, M & S Skyleisure No 1 A/C> 6,581,335 0.53%
BNP Paribas Noms (Nz) Ltd 6,410,388 0.52%
Armada Trading Pty Limited 5,005,806 0.43%
Jadeglen Investments Pty Ltd <David Thurin Family A/C> i 5,000,000 0.41%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Ocelot SPV LP 19/08/2025 96,466,591 7.05
Jagen Nominees Pty Ltd 23/06/2026 132,307,713 9.66

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
23-06-26 Jagen Nominees Pty Ltd 132,307,713 -- 9.66
16-06-26 JAF Capital Pty Ltd 15,000,000 5.04 6.14
11-05-26 JAF Capital Pty Ltd 69,000,000 -- 5.04

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
22-06-26 JAF Capital Pty Ltd 84,000,000 6.14 --
16-06-26 The Bank of New York Mellon Corporation 87,105,313 6.37 --
16-06-26 Regal Funds Management Pty Limited 78,888,189 5.77 --
10-06-26 Regal Funds Management Pty Limited 72,949,348 11.10 5.77
05-06-26 Regal Funds Management Pty Limited 56,544,333 15.23 11.10
04-06-26 Regal Funds Management Pty Limited 86,498,895 21.56 15.23
03-06-26 Regal Funds Management Pty Limited 112,910,397 31.85 21.56
04-12-25 The Bank of New York Mellon Corporation 5,250,960 7.50 6.37

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
CYV Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.